The Alzheimer’s Paradox: Early Diagnosis Is Here. Effective Treatment Isn’t
The brain’s immune system enters the picture

Another emerging research direction concerns TREM2, a receptor involved in regulating microglia: the brain’s resident immune cells. These cells help remove cellular debris and respond to damage, including the accumulation of abnormal proteins.
Researchers have investigated whether stimulating TREM2 could improve the brain’s ability to manage Alzheimer’s pathology. One experimental antibody, AL002, was developed specifically for this purpose. However, its Phase 2 trial failed to demonstrate a significant clinical benefit, despite showing biological activity. The results illustrate how difficult it remains to translate promising mechanisms into effective treatments.